Up to 30% of patients with acute severe ulcerative colitis (ASUC) will require urgent colectomy despite initiation of intravenous corticosteroids and rescue therapies. Janus kinase inhibitors, such as ...

Individuals with IBD undergoing colectomy may benefit from surveillance for kidney function. Patients with inflammatory bowel disease (IBD) undergoing colectomy have higher rates of acute kidney ...

A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC) shows that, contrary to concerns, ...

The risk for colectomy declined over the past two decades among Finnish patients with newly diagnosed ulcerative colitis (UC), particularly between 2013 and 2020, when several advanced treatment ...

Please provide your email address to receive an email when new articles are posted on . Accelerated infliximab induction reduced odds of a colectomy at 2 years in acute ulcerative colitis. Therapeutic ...

Despite numerous treatments for acute severe ulcerative colitis (ASUC) that effectively reduce both symptom severity and disease complications -- including corticosteroids as the current standard of ...

Complication rates do not solely account for the differences in readmission rates among hospitals, according to a study in the Journal of the American College of Surgeons. Researchers examined 30-day ...

Medical malpractice: Suit alleges that negligent post-operative care and failure to diagnose complications after a total abdominal colectomy led to catastrophic organ failures, requiring kidney ...